Today: 9 June 2026
Browse Category

NASDAQ:ROST 21 November 2025 - 22 May 2026

Ross Stores Surges on Sales Beat as Bargain Demand Holds Up

Ross Stores Surges on Sales Beat as Bargain Demand Holds Up

Ross Stores shares jumped 5.3% in after-hours trading Thursday after the company raised its full-year sales and profit forecasts. First-quarter comparable-store sales surged 17%, with total sales up 21% to $6.0 billion and net income rising to $650 million. Ross now expects 6% to 7% same-store sales growth for fiscal 2026, up from its previous 3% to 4% outlook. Rival TJX also raised its annual forecasts this week.
22 May 2026
·
TJX stock rises as Wall Street tumbles on AI disruption fears — what investors watch next

TJX stock rises as Wall Street tumbles on AI disruption fears — what investors watch next

TJX shares rose about 1.5% to $152.36 Tuesday afternoon, bucking a broad market decline as tech stocks fell on renewed AI concerns. Value-focused retailers outperformed, with Walmart up 2.2% and Ross and Burlington each gaining around 1%. Traders are watching for TJX’s quarterly update later this month. Key labor data releases remain delayed due to a partial U.S. government shutdown.
3 February 2026
·····
US Stock Market Today, Nov. 24, 2025: Futures Rise as Fed Cut Bets Kick Off Thanksgiving Week

US Stock Market Today, Nov. 24, 2025: Futures Rise as Fed Cut Bets Kick Off Thanksgiving Week

Nasdaq 100 futures rose 0.99%, S&P 500 futures gained 0.68%, and Dow futures added 0.36% early Monday ahead of Thanksgiving week. Markets are betting on a possible Federal Reserve rate cut in December, with odds near 60% after dovish remarks from New York Fed President John Williams. Key economic data releases Monday include the Chicago Fed index and Dallas Fed survey.
24 November 2025
····
Ross Stores (ROST) Soars as Q3 2025 Earnings Smash Forecasts and Wall Street Hikes Price Targets

Ross Stores (ROST) Soars as Q3 2025 Earnings Smash Forecasts and Wall Street Hikes Price Targets

Ross Stores shares rose over 4% to $167.35 on November 21, 2025, after reporting Q3 earnings of $1.58 per share, beating estimates and last year’s $1.48. Revenue climbed 10% to $5.6 billion, with same-store sales up 7%. The company raised full-year EPS guidance and saw new analyst price target hikes. Vanguard increased its stake to nearly 12%.
21 November 2025
··

Stock Market Today

  • Nuvalent Shares Surge Near $124 Following GSK's $10.6 Billion Buyout Offer
    June 9, 2026, 10:35 AM EDT. Nuvalent's stock jumped 38.9% to $122.93 after GSK announced a $10.6 billion cash acquisition at $124 per share, reflecting a 40% premium to the last close. The deal highlights GSK's strategic move to expand its oncology portfolio beyond its current 6% share of sales, aiming to capitalize on Nuvalent's two lung cancer drugs pending FDA decisions this year. The tender offer needs the approval of at least half of Nuvalent's Class A shares and U.S. antitrust clearance. Early analyst reactions included target price adjustments but echoed caution over valuation. Nuvalent's pipeline products could face competition from existing ALK-targeted therapies by Pfizer and Roche.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop